Table 2.

¹³C NMR shifts of korormicins G–K (2–6).

No.	Korormicin
	G (2)	H (3)	I (4)	I (4)	J (5)	K (6)
	δC, mult. a	δC, mult. b	δC, mult. b	δC, mult. a	δC, mult. a	δC, mult. a
1	-	-	-	-	-	-
2	174.7, qC	168.5, qC	168.5, qC	168.5, qC	nd c	174.3, qC
3	50.0, CH	125.0, qC	125.0, qC	125.0, qC	50.0, CH	50.4, CH
4	39.9, CH2	133.7, CH	134.0, CH	134.0, CH	40.0, CH2	40.4, CH2
5	85.8, qC	87.2, qC	87.2, qC	87.2, qC	nd c	85.6, qC
6	32.4, CH2	31.2, CH2	31.1, CH2	34.6, CH2	32.9, CH2	32.8, CH2
7	8.2, CH3	8.0, CH3	8.0, CH3	8.1, CH3	8.3, CH3	8.4, CH3
8	25.9, CH3	23.9, CH3	24.1, CH3	24.2, CH3	25.9, CH3	26.2, CH3
NH	-	-	-	-	-	-
1′	172.0, qC	170.1, qC	170.2, qC	170.2, qC	nd c	171.7, qC
2′	42.3, CH2	43.9, CH2	44.0, CH2	43.1, CH2	42.7, CH2	42.7, CH2
3′	64.7, CH	63.5, CH	63.8, CH	64.6, CH	64.8, CH	65.0, CH
OH	-	-	-	-	-	-
4′	129.3 CH	132.8 CH	132.2 CH	129.4, CH	127.6, CH	129.0 CH
5′	130.0, CH	128.2, CH	128.5, CH	130.7, CH	130.6, CH	131.0, CH
6′	126.4, CH	127.8, CH	127.4, CH	127.4, CH	124.0, CH	124.7, CH
7′	132.0, CH	131.9, CH	132.5, CH	132.7, CH	136.6, CH	136.4, CH
8′	31.1, CH2	37.2, CH2	37.1, CH2	38.2, CH2	30.5, CH2	30.6, CH2
9′	55.3, CH	67.0, CH	72.1, CH	73.1, CH	128.3, CH	126.1, CH
OH	-	-	-	-	-	-
10′	56.6, CH	71.4, CH	67.7, CH	68.0, CH	129.2 CH	131.4, CH
11′	27.3, CH2	33.3, CH2	33.7, CH2	31.9, CH2	27.0, CH2	27.2, CH2
12′	29.1 d, CH2	25.4, CH2	26.3, CH2	26.0, CH2	25.4, CH2	29.1 d, CH2
13′	29.1 d, CH2	29.0 d, CH2	28.8 d, CH2	28.8 d, CH2	29.0 d, CH2	29.1 d, CH2
14′	29.1 d, CH2	29.0 d, CH2	28.6 d, CH2	28.58 d, CH2	28.6 d, CH2	29.1 d, CH2
15′	29.1 d, CH2	29.0, CH2	28.6 d, CH2	28.55 d, CH2	31.4, CH2	29.1 d, CH2
16′	31.6, CH2	31.3, CH2	31.2, CH2	31.7, CH2	22.0, CH2	31.6, CH2
17′	22.6, CH2	22.1, CH2	22.1, CH2	22.6, CH2	13.5, CH3	22.6, CH2
18′	13.9, CH3	13.9, CH3	13.9, CH3	13.9, CH3	-	14.1, CH3

^a CDCl₃; ^b DMSO-d₆; ^c No HMBC data was recorded for the qC due to low yield of 5, these carbons remain unassigned; ^d interchangeable.